About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Philadelphia | 184 Studies

Clinical Trials COPDPhiladelphia

COPD Clinical Trials in Philadelphia

Find 184 clinical trials for copd near Philadelphia, Pennsylvania. Connect with research centers in your area.

All COPD trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 184 trials

CompletedNursing-Driven Primary Palliative Care for Urban-Dwelling African Americans With Chronic Lung DiseaseIn prior work, this research team developed a telehealth primary care model (TIPC), designed in close partnership with patients and clinicians to address a widespread increase in…NCT05611125·Philadelphia, Pennsylvania CompletedSafety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) SubjectsThis is a multi-center study to evaluate the long-term safety of arformoterol 15 mcg twice daily (BID) in the treatment of subjects with moderate-to-severe COPD.NCT00909779·Birmingham, Alabama and 72 others

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedVideo-based Teach-to-goal Intervention on Inhaler Technique on Jordanian Adults With Asthma and COPDThis study was an interventional educational study that was intended to find out the effect of a video based inhaler technique education on improving inhaler technique mastery…NCT05664347·Amman

RecruitingTemple Health Chest Initiative (THCI 2.0)Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated.NCT06933758·Philadelphia, Pennsylvania

CompletedA Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDThe purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with…NCT00206167·Birmingham, Alabama and 215 others

WithdrawnHigh Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)The aim of this study is to see if the Vapotherm High Flow Therapy (HFT) device is effective to provide breathing support to patients with Chronic Obstructive Pulmonary Disease or…NCT00990119·Philadelphia, Pennsylvania

CompletedHigh Intensity Non-Invasive Positive Pressure Ventilation (HINPPV)The purpose of this pilot study is to evaluate the effect of high intensity non-invasive positive pressure ventilation (HINPPV) for stable, hypercapnic COPD patients.NCT01214200·Philadelphia, Pennsylvania

CompletedA Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)This study will assess the safety and efficacy of 5 doses GW642444 in subjects with Chonic Obstructive Pulmonary Disease (COPD)NCT00606684·Florence, Alabama and 98 others

CompletedCo-administration of Olodaterol Respimat® and Tiotropium Handihaler®The overall objective of this study is to assess efficacy and safety of 12 weeks, once daily, orally inhaled co-administration of olodaterol 5 µg (delivered by the Respimat®…NCT01694771·Florence, Alabama and 89 others

RecruitingSPIROMICS Study of Early COPD Progression (SOURCE)This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals.NCT05033990·Birmingham, Alabama and 13 others

CompletedA Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).The purpose of this long-term observational study is designed to collect additional information on incidence of cancer and cause of death among patients who have participated in…NCT00380796·Anaheim, California and 25 others

CompletedStudy To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)This study will assess the safety and efficacy of a range of oglemilast doses. The study will be 14 weeks in duration.NCT00671073·Birmingham, Alabama and 46 others

UnknownBiological Effects of Quercetin in COPDThis study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease.NCT03989271·Philadelphia, Pennsylvania

TerminatedA 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.NCT04636814·Andalusia, Alabama and 459 others

Completed26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)Stage 1 of the study is designed to provide data about the risk-benefit of 4 dose regimens of indacaterol (75, 150, 300 \& 600 µg o.d.) in order to select two doses to carry…NCT00463567·Anniston, Alabama and 343 others

TerminatedHealth Literacy Activation RCT Among the COPD Patients and Designated Support DyadThis study investigates whether increasing health literacy among COPD patients and their designated health coach during a hospital admission caused by symptoms exacerbation will…NCT03721315·Philadelphia, Pennsylvania

Enrolling by invitationStudy on Home Obstructive Respiratory ExacerbationsStrados Labs has developed the Strados™ Respiratory Care Platform, including the RESP™ Biosensor System, which encompasses a clinically validated wearable, non-invasive…NCT06544928·Philadelphia, Pennsylvania

CompletedClinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe EmphysemaThis trial is for men and women between the ages of 40 and 74 who have a confirmed diagnosis of emphysema.NCT00475007·Birmingham, Alabama and 33 others

CompletedAn Observational Study of Beta-Blocker Use in Patients With COPD and Acute MIThe study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to…NCT04717492·Birmingham, Alabama and 23 others

CompletedChronic Obstructive Pulmonary Disease (COPD) Post-hospitalization StudyThis trial is a randomized, double-blind, parallel-group, multicenter study to be conducted in the United States.NCT01110200·Birmingham, Alabama and 102 others

PreviousPage 3 of 10Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia